Your browser doesn't support javascript.
loading
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy.
De Angelis, Carmine; Nagi, Chandandeep; Hoyt, Cliff C; Liu, Linying; Roman, Kristin; Wang, Chichung; Zheng, Yi; Veeraraghavan, Jamunarani; Sethunath, Vidyalakshmi; Nuciforo, Paolo; Wang, Tao; Tsimelzon, Anna; Mao, Sufeng; Hilsenbeck, Susan G; Trivedi, Meghana V; Cataldo, Maria Letizia; Pavlick, Anne; Wolff, Antonio C; Weigelt, Britta; Reis-Filho, Jorge S; Prat, Aleix; Gutierrez, Carolina; Osborne, Charles Kent; Rimawi, Mothaffar F; Schiff, Rachel.
Afiliação
  • De Angelis C; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Nagi C; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Hoyt CC; Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy.
  • Liu L; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Roman K; Akoya Biosciences, Hopkinton, Massachusetts.
  • Wang C; Akoya Biosciences, Hopkinton, Massachusetts.
  • Zheng Y; Akoya Biosciences, Hopkinton, Massachusetts.
  • Veeraraghavan J; Akoya Biosciences, Hopkinton, Massachusetts.
  • Sethunath V; Akoya Biosciences, Hopkinton, Massachusetts.
  • Nuciforo P; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Wang T; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Tsimelzon A; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Mao S; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Hilsenbeck SG; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Trivedi MV; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Cataldo ML; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Pavlick A; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Wolff AC; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Weigelt B; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Reis-Filho JS; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Prat A; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Gutierrez C; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Osborne CK; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Rimawi MF; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.
  • Schiff R; Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
Clin Cancer Res ; 26(3): 738-745, 2020 02 01.
Article em En | MEDLINE | ID: mdl-31653641
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfócitos / Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos do Interstício Tumoral / Receptor ErbB-2 / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfócitos / Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos do Interstício Tumoral / Receptor ErbB-2 / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos